All Posts

Dr. Peloquin was promoted to distinguished professor, the highest faculty honor at UF.

By allowing chemotherapy regimens to be personalized, a genetic score holds promise for improving treatment results in patients with acute myeloid leukemia (AML) who have traditionally had poor outcomes, UF Health researchers have found.

Dr. Cavallari's appointment follows two years of service in an interim chair role, during which she gained valuable experience leading the department’s 23 full-time faculty members.

The UF Cardio-Oncology Symposium on April 3 provided an engaging forum to spark new research collaborations. The event showcased how innovations in precision medicine, early detection and multidisciplinary collaboration are directly enhancing patient care.

Lamba will serve a four-year term overseeing fellows, working groups, and section business and best practices.

The Feb. 17 event saw 112 poster presentations and 12 oral presentations from UF pharmacy students and trainees.

PARADIGM at UF invites applications for its postdoctoral fellowship program in genomic medicine.

UF Health researchers have used a promising approach by integrating CRISPR/cas9-based drug screening with patients’ clinical outcome to identify genes and pathways that predict how patients will respond to the standard firstline chemotherapy treatment regimen used to treat patients with acute myeloid leukemia, or AML.

Al Saeed was one of two graduate students nationally to receive a 2024 ACCP Foundation Futures Grant.

Nguyen’s appointment marks the first time that a UF College of Pharmacy faculty member has held this position.